All together, these data suggest that the inhibition of CA-IX, by SLC-0111 and AA-06-05, increases the activation of apoptotic pathways on tumor cells by the activation of p-ERK1/2 - p53 pathway, corroborating the functional results of survival assay. The gene discussed is TP53; the disease is neoplasm.